AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Emsita-M SR 100/500 Tablet PR

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Emsita-M SR 100/500 Tablet PR

Diabex Duo 100/500mg extended-release tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabex Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and concurrent medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician supervision. Adherence to your prescribed diet and exercise plan is crucial for effective diabetes control. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; understand its recognition and management. This medication isn't suitable for all individuals. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption before starting treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Interaction with other medications is possible; disclose all current medications to your physician to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout therapy.

Primary Ingredients of Emsita-M SR 100/500 Tablet PR

No text provided. Please provide the text you want me to rephrase.

Uses of Emsita-M SR 100/500 Tablet PR

Managing Type 2 diabetes

Major Benefits of Emsita-M SR 100/500 Tablet PR:

Follow your physician's instructions or consult the product label for dosage information. Administer Emsita-M SR 100/500 Tablet PR with a meal.

Common Side effects of Emsita-M SR 100/500 Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Emsita-M SR 100/500 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Emsita-M SR 100/500 Tablet PR with a meal.

How Emsita-M SR 100/500 Tablet PR works:

Emsita-M SR 100/500 Tablet PR combines sitagliptin and metformin to improve blood glucose management. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Emsita-M SR 100/500 Tablet PR with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Emsita-M SR 100/500 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Emsita-M 100/500 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Emsita-M SR 100/500 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Emsita-M SR 100/500 Tablet PR due to potential safety concerns. Medical advice is recommended.

What if you forget to take Emsita-M SR 100/500 Tablet PR :

Should you forget to take a dose of Emsita-M SR 100/500 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Emsita-M SR 100/500 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Emsita-M SR 100/500 Tablet PR

Emsita-M SR 100/500 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Emsita-M SR 100/500 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Emsita-M SR 100/500 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Emsita-M SR 100/500 Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Emsita-M SR 100/500 Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Emsita-M SR 100/500 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Emsita-M SR 100/500 Tablet PR combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Emsita-M SR 100/500 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Avoid Emsita-M SR 100/500 Tablet PR if you are allergic to any of its ingredients. This medication is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita-M SR 100/500 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Emsita-M SR 100/500 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Emsita-M SR 100/500 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Emsita-M SR 100/500 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Emsita-M SR 100/500 Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Emsita-M SR 100/500 Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Emsita-M SR 100/500 Tablet PR with alcohol is unsafe and may raise your risk of lactic acidosis.
Emsita-M SR 100/500 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding Emsita-M in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Emsita-M and seek immediate medical attention.
Prolonged use of Emsita-M SR 100/500 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency can cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake is recommended at least annually, according to some research.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Emsita-M SR 100/500 Table...
160
MRP 186
13% off